From CNBC: 2025-06-10 14:55:00

Health and Human Services Secretary Robert F. Kennedy Jr. has fired all 17 members of the Advisory Committee on Immunization Practices (ACIP). Experts warn this move could undermine science, increase public distrust in vaccinations and federal health agencies, and threaten public health by lowering immunization rates against childhood diseases.

Kennedy’s actions as head of HHS have dismantled U.S. vaccination policy standards and eroded public confidence in immunizations. Some experts fear he may appoint members sympathetic to his anti-vaccine views, leading to politicized recommendations that could deter Americans from getting vaccinated, potentially causing lower vaccination rates and increased risk of vaccine-preventable diseases.

HHS did not provide a timeline for appointing new ACIP members. Kennedy claimed the current panel had conflicts of interest, but experts say these allegations are unfounded and could have a negative impact on public health. The American Academy of Physician Associates stressed the need for a transparent process in reconstructing the committee with diverse provider voices.

Experts warn that Kennedy’s restacked panel may restrict vaccination eligibility, delay vaccine availability, and lower vaccination rates. This could lead to an increased risk of vaccine-preventable diseases spreading, especially with an ongoing measles outbreak and the upcoming school year. Kennedy’s decision contradicts a promise he made during his confirmation hearings. Senator Kennedy informed Senator Cassidy that he will not alter the Advisory Committee on Immunization Practices (ACIP). Cassidy expressed concern that new ACIP members may lack vaccine knowledge. Wall Street analysts warned that Kennedy’s decision could impact vaccine manufacturers, causing uncertainty in future recommendations but overall impact is expected to be limited.

New Pfizer COVID-19 vaccine, COMIRNATY®, is now available at CVS Pharmacy in Eagle Rock, CA. Wall Street analysts believe Kennedy’s decision could pose a risk to vaccine manufacturers as new ACIP members may be more critical. However, the impact is expected to be minimal as current FDA and CDC leadership have been less negative towards the sector.

Kennedy’s decision not to alter ACIP may have implications for vaccine manufacturers, with potential risks to future recommendations. New Pfizer COVID-19 vaccine, COMIRNATY®, is now available at CVS Pharmacy in Eagle Rock, CA. Wall Street analysts warn of uncertainty in the industry, but believe the impact will be limited overall.



Read more at CNBC: RFK Jr. firing of CDC vaccine advisors effects on public health